Publications

  1. Bruce B, Gehin J, Genins S, Abril A, Rivera F, Hines S, Wang B, Ames G, Ames S. (546) The development of an interdisciplinary treatment program for fibromyalgia in a tertiary medical center that targets the functioning and distress of patients and the frustration of physicians. J Pain 2016 Apr; 17 (4S):S111 Epub 2016 Mar 24
    View PubMed
  2. Pullen SJ, Rasmussen KG, Angstman ER, Rivera F, Mueller PS. The safety of electroconvulsive therapy in patients with prolonged QTc intervals on the electrocardiogram. J ECT. 2011 Sep; 27(3):192-200.
    View PubMed
  3. Rivera FA, Lapid MI, Sampson S, Mueller PS. Safety of electroconvulsive therapy in patients with a history of heart failure and decreased left ventricular systolic heart function. J ECT. 2011 Sep; 27(3):207-13.
    View PubMed
  4. Campo RE, Rosa I, Lichtenberger PN, Suarez G, Rivera FA, Jayaweera DT, Rodriguez AE, Wahlay NA, Kolber MA. Effect of class-specific therapy interruption on persistence of HIV type 1 antiretroviral resistance. AIDS Res Hum Retroviruses. 2003 Aug; 19(8):653-6.
    View PubMed
  5. Campo RE, Lichtenberger PN, Rosa I, Suarez G, Rivera FA, Rodriguez AE, Jayaweera DT, Wahlay NA, Kolber MA. Differences in the frequency of resistance to antiretroviral drug classes among human immunodeficiency virus type 1 clinical isolates. J Clin Microbiol. 2003 Jul; 41(7):3376-8.
    View PubMed